Composition
- Active ingredients
- PLERIXAFOR 24MG/1.2ML (20MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA215334-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA215698-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionThis page
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA206644-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA205182-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA213672-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA208980-001 · Discontinued
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA217560-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA211901-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA205197.
At a glance
- Brand name
- Plerixafor
- Route
- Subcutaneous
- Dosage form
- Solution
- Applicant
- Teva Pharms USA Inc
- Status
- Discontinued
- FDA approval
- 24 Jul 2023
- Application
- ANDA205197-001